Products | Biopsy Systems | March 23, 2017

UroNav Fusion Biopsy System

UroNav Fusion Biopsy System

Related Content

Immunis, Inc. has announced that a partnership with Springbok Analytics to implement their MRI-based AI muscle analysis technology in its Phase 1/2a Clinical Trial, assessing the efficacy of its novel secretome therapeutic (IMMUNA) in targeting sarcopenia.
News | Radiology Business
Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx
News | Radiopharmaceuticals and Tracers
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Professional registration is open for RSNA 2024
News | RSNA
RSNA 2024 Registration Is Open

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
GPT-4V, an AI model, often made mistakes when describing the medical image and explaining its reasoning behind the diagnosis—even in cases where it made the correct final choice.
News | Artificial Intelligence
NIH Findings Shed Light on Risks and Benefits of Integrating AI into Medical Decision-making

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
Agreement to acquire business adds innovative, real-time image recognition technology and expertise to GE HealthCare’s portfolio of AI-enabled devices
News | Radiology Business
GE HealthCare Announces Agreement to Acquire Clinical Artificial Intelligence Business from Intelligent Ultrasound

July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s ...

Time July 19, 2024
arrow
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list
News | Artificial Intelligence
Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
Guidance from preoperative magnetic resonance imaging (MRI) helps clinicians deliver more precise high dose-rate (HDR) prostate brachytherapy treatments
News | Prostate Cancer
GE HealthCare’s MIM Software Introduces MIM Symphony HDR Prostate for MR Image Guidance During Procedures

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Because of its position on the front lines of diagnoses, medical imaging has a particularly unique role in mitigating healthcare inequity
Feature | Women's Health | By Jordan Bazinsky
Radiology’s Vital Mission: Paving the Path to Health Equity for Women and Minorities

Investing in women’s health should not merely be a metric on the equity dashboard — it should drive policy and tactical ...

Time July 08, 2024
arrow
The deployment of DL segmentation methods in 18F-fluciclovine PET/CT imaging represents an intriguing research direction for precision medicine in salvage prostate cancer care
News | Prostate Cancer
Deep Learning-assisted Lesion Segmentation in PET/CT Imaging: A Feasibility Study for Salvage Radiation Therapy in Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Whole-body MRI maker Prenuvo has announced the launch of a clinical research study, Project Hercules, which aims to assess the accuracy of whole-body MRI (WB-MRI) screening in predicting clinically significant diagnoses in the general population.
News | Clinical Trials
Prenuvo Announces Unprecedented Large-Scale Clinical Study of General Population Whole-Body MRI Screening

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now